日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug Prices, Rebates, and Health Plan Coverage Restrictions

药品价格、回扣和医疗保险计划承保范围限制

Beinfeld, Molly T; LaMountain, Fariel; Phillips, Glenn A; Hughes, Tom; Chambers, James D

Use of clinical outcome assessments in specialty drug coverage policies

在专科药物医保政策中使用临床结果评估

Rucker, Julia A; Poon, Jiat Ling; LaMountain, Fariel C A; Lin, Yichen; Klopchin, Megan N; Beinfeld, Molly T; Chambers, James D

Physics-Guided Hierarchical Neural Networks for Maxwell's Equations in Plasmonic Metamaterials

基于物理的分层神经网络在等离子体超材料中求解麦克斯韦方程组

Lynch, Sean; LaMountain, Jacob; Fan, Bo; Bu, Jie; Raju, Amogh; Wasserman, Daniel; Karpatne, Anuj; Podolskiy, Viktor A

Vortex beam nanofocusing and optical skyrmion generation via hyperbolic metamaterials

利用双曲超材料实现涡旋光束纳米聚焦和光学斯格明子生成

Li, Wenhao; LaMountain, Jacob; Simmons, Evan; Tan, Jiaren; Barati Sedeh, Hooman; Clabeau, Anthony; Bekele, Robel Y; Myers, Jason D; Omatsu, Takashige; Frantz, Jesse; Podolskiy, Viktor A; Litchinitser, Natalia M

What drug characteristics explain the wide range of manufacturer rebates?

哪些药物特性可以解释制造商折扣幅度如此之大的原因?

Beinfeld, Molly T; LaMountain, Fariel; Phillips, Glenn; Hughes, Tom; Neumann, Peter J; Chambers, James D

The unintended consequences of the inflation reduction act on biosimilar market incentives and Medicare savings

通胀抑制法案对生物类似药市场激励和医疗保险节省的意外后果

Beinfeld, Molly T; Ghule, Priyanka; LaMountain, Fariel; Wong, William; Ko, Stella; Chambers, James D

Biosimilar underutilization alone does not foretell a broken biologics market

生物类似药利用不足本身并不能预示着生物制剂市场将会崩溃。

LaMountain, Fariel; Beinfeld, Molly T; Wong, William; Kim, Eunice; Chambers, James D